Evidence map›Paper›PMID 19224936›Full record

ArticleEuropean journal of public health2009

Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary.

V Anna Gyarmathy, Alan Neaigus, Eszter Ujhelyi

Open access · bronzeAbstract read
In one paragraph

Article in European journal of public health, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Roma Health: An Overview of Communicable Diseases in Eastern and Central Europe.International journal of environmental research and public health · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

V Anna GyarmathyEuropean Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. anna.gyarmathy@emcdda.europa.eu
Alan Neaigus
Eszter Ujhelyi
European Monitoring Centre for Drugs and Drug Addiction · PTNew York City Department of Health and Mental Hygiene · USSzent János Kórház · HU

Funding

NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
HIV Risk and Neighborhood Networks of New IDUsR01DA014515 · NIDA · NATIONAL DEVELOPMENT &RES INSTITUTES · PI NEAIGUS, ALAN · 2003 to 2006
$3.2M
NIDA NIH HHS 5R01DA014515-02S1NIDA NIH HHS T32 DA007292
6 · The paper itself

Abstract

backgroundDrug-related infectious diseases are among the major health consequences of drug use, and any existing drug-related infection may predispose injecting drug users (IDUs) to other infections.

methodsWe assessed among IDUs in Budapest, Hungary the prevalence of and vulnerability to selected drug-related infections and co-infections. The sample consisted of 186 participants recruited between October 2005 and December 2006.

resultsWe found 0% HIV, 37% HCV, 24% HAV, and 14% past HBV infection. Infections with Herpes 1 or 2, tuberculosis, Chlamydia, syphilis, and gonorrhoea were 79%, 12%, 7%, 4%, and 0%, respectively. Co-infection with HAV/HCV was 12%, HBV/HCV 9%, HAV/HBV 7%, and HAV/HBV/HCV 4%. Those over age 30, the ethnic Roma, and the homeless were more likely to have any hepatitis and a higher number of drug-related infections. Amphetamine injectors were more likely to have a higher number of drug-related infections and those who travelled within Hungary were more likely to have any STI. However, those who worked at least part time and those who were in treatment were less likely to have drug-related infections.

conclusionsThese results highlight the need of interventions in Hungary to reach and focus on marginalized (Roma or homeless) IDUs and address not only injecting and sex risk, but also hygienic living and injecting conditions. Furthermore, structural interventions to increase social integration (working or being in treatment) may improve welfare and decrease drug use and infection risk tied to drug use/injection among disadvantaged, marginalized, mostly minority populations.

Indexed as

Drug UsersAdultAnalysis of VarianceEuropeFemaleHumansHungaryInfectionsMalePrevalenceRisk FactorsSex FactorsSocioeconomic FactorsSubstance Abuse, Intravenous

Identifiers

PMID19224936
PMCPMC2724848
OpenAlexW2108498296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.